Lv7
4478 积分 2021-08-05 加入
Upadacitinib Versus Tofacitinib in Anti‐ MDA5 ‐Positive Dermatomyositis With Interstitial Lung Disease: A Multi‐Centre Cohort Study Emulating a Target Trial
2天前
已完结
Validation of EULAR primary Sjögren’s syndrome disease activity (ESSDAI) and patient indexes (ESSPRI)
10天前
已完结
EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjögren's syndrome
10天前
已完结
BCMA-Targeted T-Cell Engager for Autoimmune Hemolytic Anemia after CD19 CAR T-Cell Therapy
1个月前
已完结
Bispecific T cell engagers for treatment-refractory autoimmune connective tissue diseases
1个月前
已完结
Microenvironmental niches dictate divergent fibroblast fates in reversible versus progressive lung fibrosis
1个月前
已完结
The U.S. Food and Drug Administration’s Perspective on Chimeric Antigen Receptor T-Cell Therapies for Autoimmune and Rheumatic Conditions
2个月前
已完结
China’s innovation in translational medicine: rethinking early-stage clinical development
2个月前
已完结
Autologous CD7 CAR-T cells generated without T cell pre-selection in pediatric patients with relapsed/refractory T-ALL: A phase I trial
3个月前
已完结
Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial
3个月前
已完结
皖公网安备34019202002308
